Techniques for Developing Herbal Tonics for Precautionary Medicine

Dik Feng Zhang^*
*Correspondence: Dik Feng Zhang, School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, P.R. China, Email:

Introduction

Despite being utilised for a variety of pathological disorders, herbal medicine is perhaps more suitable for preventive measures due to its general character. Strong historical evidence of herbal medicine's efficacy exists, however it is clearly lacking when compared to the standards of contemporary clinical sciences. Here, a strategy is suggested for the development and application of traditional herbal remedies based on scientific data [1].

For the elderly, disease prevention is particularly crucial. The most appropriate topic for an example-based presentation is definitely the cardiovascular sector. Cardiovascular diseases continue to be the leading causes of death in modern times. Active maintenance of artery integrity has made significant contributions, and therapeutic drugs that support efficient circulation have also delayed vascular accidents. Despite the tremendous hopes, the incessant quest for innovative agents that can enhance cardiovascular health has resulted from the inability to completely reverse progressive arterial occlusions [2].

Description

Numerous herbal products mentioned in ancient Chinese medical texts have outstanding track records for either acute treatment-such as angina relief-or for maintaining circulatory health. In the current era of evidence-based medicine, one still needs to further prove the experience-based assumptions despite the belief that historical records do offer relevant and potentially valid information. The Research Institute of Chinese Medicine in Hong Kong has been creating a realistic methodology to demonstrate the efficacy of novel herbal medicine formulas that address particular clinical issues. Viral infections, malignancies, and typical issues affecting the aged including dementia and cardiovascular health are just a few of the challenging conditions that still don't have a perfect cure. Just use example of a cardiovascular tonic created to maintain cardiovascular health in this study. In reality, there are numerous other areas of common health concern that exist and demand equal attention. These areas may require additional preventative and maintenance measures in addition to typical quality treatments [3,4].

Currently, especially in wealthy nations, humans cannot survive well without medicine. Although a number of technological platforms have accelerated the production of therapeutic agents from herbal remedies, drug development is still a time-consuming procedure with a poor success rate and significant upfront costs. A newly synthesised molecule must develop into a viable medicinal treatment for around 10 to 15 years on average, and it cost roughly €1 billion in 2006. Big Pharma spent over $50 billion in 2005, more than twice as much as it did in 1996. However, in that year, the Food and Drug Administration (FDA) in the USA only approved 22 new pharmaceuticals, compared to 53 new drugs that were released to the market in 1996. Only one or two in ten thousand of these chemical compounds have been clinically effective and safe enough for regulatory agencies to approve them, despite the lengthy development process. In fact, in the last rounds of clinical trials, nearly half of all medication proposals fail. Additionally, some new medications must be pulled off the market shortly after receiving approval due to serious side effects and clinical hazards that were missed in Phase III trials. For instance, the 1999-released drug Rofecoxib (Vioxx) was discontinued in 2004 due to a higher risk of heart attack in users. The outcome was that the medicine was only available on the market for 5 years, which was made worse by the enormous amount ($4.85 billion) of compensation associated with legal settlements. Many pharmaceutical companies are now concentrating on the creation of plant-derived medications because the synthesis of synthetic compounds for therapeutic application is, on the whole, a random process that could lead to serendipitous discovery [5].

Conclusion

Traditional beliefs and practises, as well as traditional medical practises in general, are frequently disregarded. Numerous people use herbal medications, and scientists are becoming more interested in the scientific validation and molecular analysis of herbal effects. By protecting biodiversity and using natural resources for drug discovery, ecological ethics should be preserved. Man does not have the authority to indiscriminately eradicate any species or tamper with genes to produce transgenic crops for his or her own gain. One of Earth's inhabitants is people.

Conflicts of Interest

The authors declare no conflict of interest.

References

1. Barden, Christopher J., and Donald F. Weaver. “The rise of micropharma.” Drug Discov Today 15(2010):84-87.

Google Scholar, Crossref, Indexed at

2. Graul, Ann I., Laura Revel, Meritxell Barrionuevo, and Elisabet Cruces, et al. “The year’s new drugs & biologics-2008.” Drug News and Perspect 22(2009):7-29.

Google Scholar, Crossref, Indexed at

3. Pan, Si-Yuan, Si-Hua Gao, Shu-Feng Zhou, and Min-Ke Tang, et al. “New perspectives on complementary and alternative medicine: an overview and alternative therapy.” Altern Ther Health Med 18(2012):20-36.

Google Scholar, Indexed at

4. He, Shu-Ming, Eli Chan, and Shu-Feng Zhou. “ADME properties of herbal medicines in humans: evidence, challenges andstrategies.” Curr Pharm Des 17(2011):357-407.

Google Scholar, Crossref, Indexed at

5. Koon, C. M., K. S. Woo, P. C. Leung, and K. P. Fung. “Salviae Miltiorrhizae Radix and Puerariae Lobatae Radix herbal formula mediates anti-atherosclerosis by modulating key atherogenic events both in vascular smooth muscle cells and endothelial cells.” J Ethnopharmacol 138(2011):175-183.

Google Scholar, Crossref, Indexed at